Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACUITY: Bivalirudin vs Heparin in ACS
NCT00093158Phase 3Completed
- Sponsor
- The Medicines Company
- Start
- Aug 2003
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bivalirudin in acute coronary syndrome (ACS), unstable angina, non-ST-elevation myocardial infarction (NSTEMI), sponsored by The Medicines Company. Started Aug 2003; status: completed.
02
Drugs
bivalirudin
03
Conditions
acute coronary syndrome (ACS)unstable anginanon-ST-elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT00093158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00093158.